High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy

BACKGROUND: Liver transplantation (LT) presents a curative treatment option in patients with early stage hepatocellular carcinoma (HCC) who are not eligible for resection or ablation therapy. Due to a risk of up 30% for waitlist drop-out upon tumor progression, bridging therapies are used to halt tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauer, Ulrike, Gerum, Sabine, Roeder, Falk, Münch, Stefan, Combs, Stephanie E, Philipp, Alexander B, De Toni, Enrico N, Kirstein, Martha M, Vogel, Arndt, Mogler, Carolin, Haller, Bernhard, Neumann, Jens, Braren, Rickmer F, Makowski, Marcus R, Paprottka, Philipp, Guba, Markus, Geisler, Fabian, Schmid, Roland M, Umgelter, Andreas, Ehmer, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240047/
https://www.ncbi.nlm.nih.gov/pubmed/34239274
http://dx.doi.org/10.3748/wjg.v27.i24.3630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240047/
https://www.ncbi.nlm.nih.gov/pubmed/34239274
http://dx.doi.org/10.3748/wjg.v27.i24.3630

Ejemplares similares